Tuesday, August 9, 2022
Stop Diabetes
No Result
View All Result
  • Home
  • Diabetes
  • Diabetic Lifestyle
  • The Best Habits
  • Reversing Diabetes
  • Diabetes Nutrition
  • Shop
  • Contact Us
No Result
View All Result
  • Home
  • Diabetes
  • Diabetic Lifestyle
  • The Best Habits
  • Reversing Diabetes
  • Diabetes Nutrition
  • Shop
  • Contact Us
No Result
View All Result
Stop Diabetes
No Result
View All Result
Home Diabetes Diabetes Diabetes Types

AstraZeneca’s Diabetes Drug Farxiga Falls Short in COVID-19 Study

diabetes-admin by diabetes-admin
April 12, 2021
in Diabetes Types
0
AstraZeneca’s Diabetes Drug Farxiga Falls Short in COVID-19 Study
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter


AstraZeneca’s Diabetes Drug Farxiga Falls Short in COVID-19 Study

Tada Photos/Shutterstock

AstraZeneca’s diabetes drug Farxiga (dapagliflozin) failed to reach endpoints in a Section III research as a possible therapy for hospitalized COVID-19 sufferers severe danger of growing issues.

AstraZeneca, which had partnered with Saint Luke’s Mid America Coronary heart Institute to conduct the research, introduced the damaging end result this morning. The failure follows the continued difficulties the U.Okay.-based pharma firm has had with its COVID-19 vaccine in components of Europe and Asia.

Within the announcement, AstraZeneca stated Farxiga didn’t obtain statistical significance within the Section III DARE-19 research after a 30-day interval. The first endpoint of the research was the prevention measuring organ dysfunction and all-cause mortality. Moreover, AstraZeneca stated Farxiga fell quick in aiding hospitalized sufferers with restoration.

The security and tolerability of Farxiga remained per the well-established security profile of the medication.

Farxiga is a first-in-class, oral, once-daily SGLT2 inhibitor. The drug has been authorised by the U.S. Meals and Drug Administration to reduce the risk of hospitalization for coronary heart failure in sufferers with sort 2 diabetes and established heart problems or a number of cardiovascular danger elements.

The DARE-19 research was the primary late-stage research that evaluated the protection and efficacy of SGLT2 inhibitors in 1,250 hospitalized COVID-19 sufferers who had the chance elements in growing extreme issues.

Sufferers who have been enrolled within the research had a medical historical past of cardiac, renal, and metabolic comorbidities, together with hypertension, coronary heart failure, persistent kidney illness and atherosclerotic heart problems. These comorbidities can result in the demise of sufferers.

The complete information from the research was not supplied by AstraZeneca this morning. The corporate stated it intends to share the entire information on the American School of Cardiology Scientific Periods in Could. Mene Pangalos, AstraZeneca’s govt vp of BioPharmaceuticals R&D, famous that till AstraZeneca launched the Section III research, there was little information on the usage of SGLT2 inhibitors in hospitalized COVID-19 sufferers. Even with lacking the research’s main endpoints, Pangalos stated the research has helped fill a “data hole” because the world continues to grapple with the COVID-19 pandemic.

Farxiga definitely isn’t the one drug thrown at COVID-19 to fail in medical research. Emergent BioSolutions just lately noticed the failure of its immunoglobulin treatment in opposition to the novel coronavirus. Different firms have fallen quick as properly. In March, BioSpace tallied up the variety of failed research, which can be found here.

“DARE-19 supplied essential information on the potential advantages and dangers of utilizing SGLT2 inhibitors to deal with hospitalized sufferers with COVID-19. Whereas the trial didn’t obtain statistical significance, the findings are very fascinating and worthwhile, and can inform future medical science,” Mikhail N. Kosiborod, heart specialist at Saint Luke’s Mid America Coronary heart Institute and principal investigator of DARE-19, stated in an announcement.

There’s a query of whether or not or not SGLT2 inhibitors reminiscent of Farxiga can improve the chance for a uncommon complication in diabetes sufferers with COVID-19. In January, a research at Brigham and Girls’s Hospital in Massachusetts identified a rare side effect in five COVID-19 patients taking SGLT2 inhibitors. These 5 sufferers developed a facet impact referred to as euDKA, or euglycemic diabetic ketoacidosis. As BioSpace reported on the time, the researcher believes COVID-19 could “improve the chance of euDKA by binding to cells on the pancreas that produce insulin.”



Source link

READ ALSO

Diabetes and Me: Can I still eat carbohydrates?

Does COVID-19 Raise the Risk for Diabetes?

Tags: AstraZenecasCOVID19diabetesDrugfallsFarxigaShortStudy

Related Posts

Diabetes and Me: Can I still eat carbohydrates?
Diabetes Types

Diabetes and Me: Can I still eat carbohydrates?

May 18, 2022
Does COVID-19 Raise the Risk for Diabetes?
Diabetes Types

Does COVID-19 Raise the Risk for Diabetes?

May 17, 2022
Increasing Impact of HPV Vaccination Seen in the United States – Consumer Health News
Diabetes Types

Increasing Impact of HPV Vaccination Seen in the United States – Consumer Health News

May 17, 2022
Fractyl Health to Present New Data on Revita® DMR in Type 2 Diabetes at Digestive Disease Week 2022
Diabetes Types

Fractyl Health to Present New Data on Revita® DMR in Type 2 Diabetes at Digestive Disease Week 2022

May 17, 2022
Cardiovascular disease triggered by type 2 diabetes and cognitive impairment, research shows
Diabetes Types

Cardiovascular disease triggered by type 2 diabetes and cognitive impairment, research shows

May 17, 2022
Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada
Diabetes Types

Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada

May 17, 2022

POPULAR NEWS

Fruit Street Health launches employer advisory board to manage healthcare costs with digital health

Fruit Street Health launches employer advisory board to manage healthcare costs with digital health

March 30, 2021
Glucofort Reviews (Warning) Fake Results or Real Ingredients?

Glucofort Reviews (Warning) Fake Results or Real Ingredients?

July 31, 2021
GlucoFreeze Reviews: Shocking Scam Complaints to Know About?

GlucoFreeze Reviews: Shocking Scam Complaints to Know About?

August 11, 2021
Glucofort Reviews (UPDATED) Scam Reports or Real Customer Success Stories?

Glucofort Reviews (UPDATED) Scam Reports or Real Customer Success Stories?

May 14, 2021
CrossFit Coach Helps Greg Upchurch Shed 140 Pounds, Put Diabetes into Remission During COVID

CrossFit Coach Helps Greg Upchurch Shed 140 Pounds, Put Diabetes into Remission During COVID

May 5, 2021

EDITOR'S PICK

Diabetes: The Exercise Prescription

Diabetes: The Exercise Prescription

July 4, 2022
What is Type 1 Diabetes? Diabetes explained for children – Ask Dr.Smarty

What is Type 1 Diabetes? Diabetes explained for children – Ask Dr.Smarty

August 15, 2021
Tauriga Sciences Inc. Generates Record Daily E-Commerce Revenue for Sunday, July 25, 2021

Tauriga Sciences Inc. Generates Record Daily E-Commerce Revenue for Sunday, July 25, 2021

July 26, 2021
Rising Diabetic Patients Pool Prompts High Demand for Smart Insulin Pens, Market Estimated to be valued at US$ 70.4 Mn by 2027 End: TMR

Rising Diabetic Patients Pool Prompts High Demand for Smart Insulin Pens, Market Estimated to be valued at US$ 70.4 Mn by 2027 End: TMR

June 21, 2021

Recent Posts

  • 3 commonly asked questions about breastfeeding and chestfeeding, answered by a lactation consultant
  • Just 2 Minutes of Walking After a Meal Is Surprisingly Good for You
  • How to Use the Principle of Specificity for Exercise
  • Realistic Ways To Limit Processed Foods In Your Diet
  • Man With Diabetes, Depression Missing in Maywood – Vigour Times

Categories

  • Alternative Therapies for Diabetes
  • Diabetes
  • Diabetes
  • Diabetes Education
  • Diabetes Nutrition
  • Diabetes Tips
  • Diabetes Types
  • Diabetes Videos
  • Diabetic Insurance
  • Diabetic Lifestyle
  • Diabetic Medication
  • Diabetic Shop
  • Diabetic Specialists – Doctors
  • Prediabetes
  • Reversing Diabetes
  • Sports
  • Symptoms
  • The Best Habits

Follow us

Contact Us

  • Privacy & Policy
  • About Us
  • Contact Us

© 2021 Stop Diabetes

No Result
View All Result
  • Home
  • Diabetes
  • Diabetic Lifestyle
  • The Best Habits
  • Reversing Diabetes
  • Diabetes Nutrition
  • Shop
  • Contact Us

© 2021 Stop Diabetes

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?